Mesoblast LimitedASX: MSB

MSB to Begin Phase 2 Trial of MPCs in Diabetic Nephropathy

· Issued by Mesoblast Limited

Filed with ASX ·

On 6ix: 6ix.com/news/msb-to-begin-phase-2-trial-of-mpcs-in-diabetic-nephropathy

Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call

6ix hasn’t read this filing yet.

Mesoblast Limited on 6ix

In the deck